US Stock MarketDetailed Quotes

BiomX (PHGE)

Watchlist
  • 0.7896
  • -0.0604-7.11%
Close May 1 16:00 ET
  • 0.7855
  • -0.0041-0.52%
Post 20:01 ET
6.92MMarket Cap-0.04P/E (TTM)

BiomX (PHGE) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
11.29%-7.18M
45.63%-6.11M
23.28%-8.71M
-73.72%-36.98M
-0.75%-6.29M
-36.73%-8.1M
-175.62%-11.24M
-125.09%-11.36M
26.83%-21.29M
12.92%-6.24M
Net income from continuing operations
-195.06%-9.17M
-235.03%-6.04M
55.80%-7.66M
32.26%-17.73M
-164.31%-14.51M
221.96%9.64M
169.74%4.47M
-172.39%-17.33M
7.59%-26.17M
6.71%-5.49M
Operating gains losses
103.56%730K
88.19%-1.39M
-109.80%-857K
-36,022.54%-25.51M
---1.97M
---20.51M
---11.77M
--8.74M
--71K
----
Depreciation and amortization
285.40%1.24M
-11.78%292K
3.06%236K
107.00%1.8M
334.43%921K
47.03%322K
52.53%331K
2.69%229K
-65.44%871K
-66.03%212K
Other non cash items
-175.00%-27K
114.86%301K
88.86%-51K
-713.05%-2.49M
-114.34%-41K
209.09%36K
-1,093.14%-2.03M
-798.04%-458K
202.53%406K
145.25%286K
Change In working capital
-150.89%-399K
101.25%29K
61.75%-1.04M
-220.88%-2.99M
172.55%1.26M
-51.09%784K
-241.23%-2.32M
-380.60%-2.72M
155.92%2.48M
-5.91%-1.74M
-Change in payables and accrued expense
-185.04%-1.1M
74.73%-822K
32.10%-1.29M
-337.20%-4.15M
84.23%-291K
28.49%1.29M
-328.76%-3.25M
-262.28%-1.9M
133.16%1.75M
-129.48%-1.85M
-Change in other current assets
164.57%656K
254.36%854K
-56.94%242K
2.81%842K
653.57%1.06M
-263.87%-1.02M
3.43%241K
422.99%562K
-14.33%819K
108.84%140K
-Change in other working capital
-91.76%42K
-100.43%-3K
100.43%6K
439.78%316K
1,606.06%497K
2,528.57%510K
5,430.77%693K
-5,223.08%-1.38M
12.26%-93K
-104.42%-33K
Cash from discontinued investing activities
Operating cash flow
11.29%-7.18M
45.63%-6.11M
23.28%-8.71M
-73.72%-36.98M
-0.75%-6.29M
-36.73%-8.1M
-175.62%-11.24M
-125.09%-11.36M
26.83%-21.29M
12.92%-6.24M
Investing cash flow
Cash flow from continuing investing activities
-100.00%-2K
7.41%58K
-92.31%51K
-63.35%715K
83.33%-1K
96.88%-1K
5,500.00%54K
-66.68%663K
192.60%1.95M
-100.41%-6K
Net PPE purchase and sale
-100.00%-2K
7.41%58K
--51K
206.12%52K
83.33%-1K
96.88%-1K
5,500.00%54K
--0
54.21%-49K
81.25%-6K
Net business purchase and sale
----
----
----
--663K
----
----
----
----
--0
----
Net investment purchase and sale
----
----
----
--0
--0
--0
--0
--0
200.00%2M
--0
Net other investing changes
----
----
----
----
----
--0
--0
--663K
----
----
Cash from discontinued investing activities
Investing cash flow
-100.00%-2K
7.41%58K
-92.31%51K
-63.35%715K
83.33%-1K
96.88%-1K
5,500.00%54K
-66.68%663K
192.60%1.95M
-100.41%-6K
Financing cash flow
Cash flow from continuing financing activities
54K
85.71%-29K
-69.43%11.91M
1,223.70%38.37M
69.94%-398K
0
-104.53%-203K
3,611.90%38.98M
892.81%2.9M
-1.32M
Net issuance payments of debt
--0
--0
--0
-152.69%-10.75M
--0
--0
--0
-2,464.92%-10.75M
---4.25M
---1.32M
Net common stock issuance
--54K
--0
39,210.53%7.47M
-99.75%19K
--0
--0
--0
-98.71%19K
2,641.76%7.49M
--0
Net preferred stock issuance
--0
--0
--0
--21.27M
--0
--0
--0
--21.27M
--0
--0
Proceeds from stock option exercised by employees
--0
100.00%2K
-84.24%4.53M
--28.75M
--0
--0
--1K
--28.75M
--0
--0
Net other financing activities
--0
84.80%-31K
72.47%-87K
-175.68%-918K
---398K
--0
---204K
---316K
-1,852.63%-333K
--0
Cash from discontinued financing activities
Financing cash flow
--54K
85.71%-29K
-69.43%11.91M
1,223.70%38.37M
69.94%-398K
--0
-104.53%-203K
3,611.90%38.98M
892.81%2.9M
---1.32M
Net cash flow
Beginning cash position
-53.58%15.19M
-51.88%21.23M
13.31%17.98M
-50.88%15.86M
5.38%24.65M
6.69%32.71M
45.58%44.12M
-50.88%15.86M
-48.82%32.29M
-38.48%23.39M
Current changes in cash
11.94%-7.13M
46.60%-6.08M
-88.50%3.25M
112.84%2.11M
11.67%-6.69M
-11.53%-8.1M
-2,932.34%-11.39M
1,510.57%28.28M
46.82%-16.44M
-32.84%-7.57M
Effect of exchange rate changes
-60.00%14K
340.00%36K
109.68%3K
-83.33%1K
-72.09%12K
537.50%35K
64.29%-15K
-338.46%-31K
-94.34%6K
230.30%43K
End cash Position
-67.27%8.07M
-53.58%15.19M
-51.88%21.23M
13.31%17.98M
13.31%17.98M
5.38%24.65M
6.69%32.71M
45.58%44.12M
-50.88%15.86M
-50.88%15.86M
Free cash flow
11.37%-7.19M
45.68%-6.11M
23.28%-8.71M
-73.46%-37.01M
-0.82%-6.3M
-36.16%-8.11M
-175.77%-11.25M
-124.65%-11.36M
26.94%-21.34M
13.21%-6.25M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 11.29%-7.18M45.63%-6.11M23.28%-8.71M-73.72%-36.98M-0.75%-6.29M-36.73%-8.1M-175.62%-11.24M-125.09%-11.36M26.83%-21.29M12.92%-6.24M
Net income from continuing operations -195.06%-9.17M-235.03%-6.04M55.80%-7.66M32.26%-17.73M-164.31%-14.51M221.96%9.64M169.74%4.47M-172.39%-17.33M7.59%-26.17M6.71%-5.49M
Operating gains losses 103.56%730K88.19%-1.39M-109.80%-857K-36,022.54%-25.51M---1.97M---20.51M---11.77M--8.74M--71K----
Depreciation and amortization 285.40%1.24M-11.78%292K3.06%236K107.00%1.8M334.43%921K47.03%322K52.53%331K2.69%229K-65.44%871K-66.03%212K
Other non cash items -175.00%-27K114.86%301K88.86%-51K-713.05%-2.49M-114.34%-41K209.09%36K-1,093.14%-2.03M-798.04%-458K202.53%406K145.25%286K
Change In working capital -150.89%-399K101.25%29K61.75%-1.04M-220.88%-2.99M172.55%1.26M-51.09%784K-241.23%-2.32M-380.60%-2.72M155.92%2.48M-5.91%-1.74M
-Change in payables and accrued expense -185.04%-1.1M74.73%-822K32.10%-1.29M-337.20%-4.15M84.23%-291K28.49%1.29M-328.76%-3.25M-262.28%-1.9M133.16%1.75M-129.48%-1.85M
-Change in other current assets 164.57%656K254.36%854K-56.94%242K2.81%842K653.57%1.06M-263.87%-1.02M3.43%241K422.99%562K-14.33%819K108.84%140K
-Change in other working capital -91.76%42K-100.43%-3K100.43%6K439.78%316K1,606.06%497K2,528.57%510K5,430.77%693K-5,223.08%-1.38M12.26%-93K-104.42%-33K
Cash from discontinued investing activities
Operating cash flow 11.29%-7.18M45.63%-6.11M23.28%-8.71M-73.72%-36.98M-0.75%-6.29M-36.73%-8.1M-175.62%-11.24M-125.09%-11.36M26.83%-21.29M12.92%-6.24M
Investing cash flow
Cash flow from continuing investing activities -100.00%-2K7.41%58K-92.31%51K-63.35%715K83.33%-1K96.88%-1K5,500.00%54K-66.68%663K192.60%1.95M-100.41%-6K
Net PPE purchase and sale -100.00%-2K7.41%58K--51K206.12%52K83.33%-1K96.88%-1K5,500.00%54K--054.21%-49K81.25%-6K
Net business purchase and sale --------------663K------------------0----
Net investment purchase and sale --------------0--0--0--0--0200.00%2M--0
Net other investing changes ----------------------0--0--663K--------
Cash from discontinued investing activities
Investing cash flow -100.00%-2K7.41%58K-92.31%51K-63.35%715K83.33%-1K96.88%-1K5,500.00%54K-66.68%663K192.60%1.95M-100.41%-6K
Financing cash flow
Cash flow from continuing financing activities 54K85.71%-29K-69.43%11.91M1,223.70%38.37M69.94%-398K0-104.53%-203K3,611.90%38.98M892.81%2.9M-1.32M
Net issuance payments of debt --0--0--0-152.69%-10.75M--0--0--0-2,464.92%-10.75M---4.25M---1.32M
Net common stock issuance --54K--039,210.53%7.47M-99.75%19K--0--0--0-98.71%19K2,641.76%7.49M--0
Net preferred stock issuance --0--0--0--21.27M--0--0--0--21.27M--0--0
Proceeds from stock option exercised by employees --0100.00%2K-84.24%4.53M--28.75M--0--0--1K--28.75M--0--0
Net other financing activities --084.80%-31K72.47%-87K-175.68%-918K---398K--0---204K---316K-1,852.63%-333K--0
Cash from discontinued financing activities
Financing cash flow --54K85.71%-29K-69.43%11.91M1,223.70%38.37M69.94%-398K--0-104.53%-203K3,611.90%38.98M892.81%2.9M---1.32M
Net cash flow
Beginning cash position -53.58%15.19M-51.88%21.23M13.31%17.98M-50.88%15.86M5.38%24.65M6.69%32.71M45.58%44.12M-50.88%15.86M-48.82%32.29M-38.48%23.39M
Current changes in cash 11.94%-7.13M46.60%-6.08M-88.50%3.25M112.84%2.11M11.67%-6.69M-11.53%-8.1M-2,932.34%-11.39M1,510.57%28.28M46.82%-16.44M-32.84%-7.57M
Effect of exchange rate changes -60.00%14K340.00%36K109.68%3K-83.33%1K-72.09%12K537.50%35K64.29%-15K-338.46%-31K-94.34%6K230.30%43K
End cash Position -67.27%8.07M-53.58%15.19M-51.88%21.23M13.31%17.98M13.31%17.98M5.38%24.65M6.69%32.71M45.58%44.12M-50.88%15.86M-50.88%15.86M
Free cash flow 11.37%-7.19M45.68%-6.11M23.28%-8.71M-73.46%-37.01M-0.82%-6.3M-36.16%-8.11M-175.77%-11.25M-124.65%-11.36M26.94%-21.34M13.21%-6.25M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More